Skip to content
No picture yet

Imbruvica 140 mg – DIN 02434407

Imbruvica is Ibrutinib 140 mg (capsule), sold in Canada. It is used for waldenstrom macroglobulinemia, b-cell chronic lymphocytic leukemia and b-cell lymphoma. It is supplied by Janssen Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Ibrutinib 140 mg

Brand
Imbruvica
Strength
140 mg
Used for
Waldenstrom macroglobulinemia, b-cell chronic lymphocytic leukemia and b-cell lymphoma
Form
Capsule
Manufacturer
Janssen Inc
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02434407

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Ibrutinib pills and guides

What is Ibrutinib used for?

Ibrutinib is used for waldenstrom macroglobulinemia, b-cell chronic lymphocytic leukemia and b-cell lymphoma.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

IMBRUVICA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

. 2 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with 17p deletion

IMBRUVICA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) with 17p deletion.

. 3 Waldenström’s Macroglobulinemia

IMBRUVICA is indicated for the treatment of adult patients with Waldenström’s macroglobulinemia (WM).

. 4 Chronic Graft versus Host Disease

IMBRUVICA is indicated for the treatment of adult and pediatric patients age 1 year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.

From the FDA-approved label on DailyMed (published Jan 08, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02434407.
  • It names Imbruvica, Ibrutinib 140 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Imbruvica by Janssen Inc.

In Canada: prescription only.

Ingredients

Active: Ibrutinib

Other Ibrutinib pills